WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1981000208) PERIPHERAL CIRCULATION FAILURE-CURING AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1981/000208    International Application No.:    PCT/JP1980/000158
Publication Date: 05.02.1981 International Filing Date: 08.07.1980
IPC:
A61K 38/17 (2006.01)
Applicants:
Inventors:
Priority Data:
79/89074 13.07.1979 JP
Title (EN) PERIPHERAL CIRCULATION FAILURE-CURING AGENT
(FR) AGENT TRAITEMENT DE DEFAILLANCES DE LA CIRCULATION PERIPHERIQUE
Abstract: front page image
(EN)A peripheral circulation failure-curing agent comprising (Alpha)1-acidic glycoprotein. Peripheral circulation failure caused by blood stream trouble resulting from induration of blood vessels due to aging, drop in blood pressure, or acceleration of fibrinolysis system can be alleviated or cured with an (Alpha)1-acidic glycoprotein which prevents coagulation or agglomeration of solid ingredients in the blood and which raises permeability of erythrocytes in the intravital micro-circulation system. (Alpha)1-acidic glycoprotein has an extremely low toxicity and is preferably administrated intravenously or intraarterially in the form of an injection.
(FR)Un agent traitement de defaillance de la circulation peripherique comprend une (Alpha)1-glycoproteine acide. Une circulation peripherique defaillante due a des troubles de la circulation sanguine resultant de l"induration des vaisseaux sanguins provoquee par le vieillissement, la chute de la pression arterielle, ou l"acceleration du systeme de fibrinolyse peut etre soignee avec une (Alpha)1-glycoproteine acide qui empeche la coagulation ou l"agglomeration d"ingredients solides dans le sang et qui augmente la permeabilite des erythrocytes dans le systeme de microcirculation intravitale. L"(Alpha)1-glycoproteine acide presente une toxicite extremement faible et est administree de preference sous forme d"injection intra-veineuse ou intra-arterielle.
Designated States:
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)